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Abstract
Background: Commensal Escherichia coli are a prominent reservoir of genes coding for antibiotic resistance and
also responsible for endogenous infections in pregnant women. We studied the factors in pregnant women
associated with carriage of multi-drug resistant (MDR) E. coli and genetic determinants of antibiotic resistance in
them.
Methods: Women attending to Obstetric and Gynaecology department outpatient clinics for routine antenatal
check-up were administered a questionnaire. Peri-anal swabs were collected for culture isolation and identification
of E.coil. Antibiotic sensitivity was done using the Kirby-Bauer disc diffusion method as recommended by the CLSI
guidelines. MICs for quinolones and third generation cephalosporins were done using the agar dilution method.
Genes coding for production of beta lactamses and for the quinolone resistance determinant were screened by
polymerase chain reaction. Rep-PCR was done on MDR isolates for detecting possible genetic similarity. Multiple
logistic regression models were used to determine the independent factors associated with carriage of MDR
isolates.
Results: A total of 710 isolates of E. coli from 710 women (mean age 26 years) were included in the study.
Resistance to at least one antibiotic tested was detected in 94% of the E. coli isolates. A total of 109 isolates were
ESBL producing and 35 isolates were MDR. In the MDR isolates MIC50 and MIC90 for quinolones and third
generation cephalosporins were high for those isolates that carried blaTEM gene (26 isolates) and blaCTX-M gene (24
isolates). Both blaTEM and blaCTX-M genes were detected in 19 isolates. The commonest Plasmid Mediated
Quinolone Resistance (PMQR) gene identified was aac(6′)-Ib-cr (n = 23/25). All isolates carrying the PMQR genes
were also positive for blaCTX-M and blaTEM gene. Mutations in gyr A and par C genes were present in all 35 MDR
isolates. The statistically significant risk factors for carriage of MDR E. coli were graduate or post-graduate education,
a self-employed status, a family size of more than 10 members, antibiotic usage in last four weeks, and history of
hospitalization in the last four weeks.
Conclusions: The presence of genes coding for extended spectrum of beta lactamases and plasmid mediated
quinolone resistance in commensal E. coli is disconcerting. The study provides strong basis good antibiotic
stewardship.
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Background
The worldwide dissemination of plasmid-borne extended-
spectrum beta-lactamases (ESBLs) in Enterobacteriaceae
has become a major global public health problem [1]. In-
appropriate use of antibiotic is the predominant selection
pressure for antibiotic resistance and aids horizontal
transfer of bacterial resistance [2]. The spread of multi-
resistant strains of bacteria in the community is
compounded with a paucity of new classes of antibiotics
effective against Gram-negative bacteria like Escherichia
coli [3]. E. coli is the most common bacterial cause of
urinary tract infections (UTI’s) in women and also a major
cause of catheter induced UTI, surgical site infections,
intra-abdominal infections and sepsis in all age groups
and meningitis in neonates [4]. The recent spread of New
Delhi metallo-beta-lactamase-1 (NDM-1) producing bac-
teria emphasises the fact that resistant bacteria respect no
geographical boundaries [5].
E. coli forms part of the bacteria commensal flora of
the human gut. It has been identified as the predomin-
ant reservoir of antibiotic resistance genes [2]. Once ac-
quired, these resistance genes are stable and are easily
transferable to pathogenic bacteria [6]. The published
studies on antibiotic resistance in commensal E. coli in
resource-poor settings are limited as resistance monitor-
ing is resource intensive, requires dedicated staff and a
well-equipped laboratory [7-9].
During pregnancy many anatomical and physiological
changes occur, which also affect the urinary tract.
Asymptomatic bacteriuria is reported to occur in 2–10%
of pregnancies and E. coli causes 70–80% of them [10].
Most infections are endogenous in origin [10]. Asymp-
tomatic bacteriuria can have serious consequences for
the foetus and/or mother [10]. However, knowledge
about the risk factors for carriage of resistant E. coli in
the women of reproductive age group is lacking in gen-
eral and especially from India. Screening the commensal
E. coli in antenatal women for antibiotic resistance pat-
tern will provide guidelines for empiric therapy espe-
cially for sick new-borns. Molecular analysis of these
isolates will provide prevalence of antibiotic resistant
genes present in E. coli in the community. The aim of
the study is to ascertain the factors associated with the
carriage of resistant commensal E. coli in pregnant
women and further to characterize the genotypic deter-
minants of antibiotic resistance in them.
Methods
Study setting, study participants, enrolment and survey
procedure
The study was conducted in Obstetrics and Gynaecology
outpatient clinics of a teaching and a non-teaching hos-
pital in Ujjain, Madhya Pradesh, India during a 15-
month period from November 2007 to February 2009.
Both the hospitals cater predominantly to rural popula-
tions. Women between 18 to 49 years of age coming for
routine antenatal check up were included in the study.
Patients requiring emergency admission or with genital
infections were not included.
Study participants were interviewed using a question-
naire containing details of patient particulars: age, family
size, education, occupation of the main breadwinner, a
reported history of antibiotic use in the previous four
weeks and reported hospitalization in the previous four
weeks. The questionnaire was piloted for one month to
ascertain feasibility of data collection and to train the
study assistants. Verbal informed consent was obtained
from all participants after explaining the purpose of the
study. The Ethics Committee of R.D. Gardi Medical Col-
lege approved the study (approval number 41/ 2007).
Sample collection, isolation and identification of E. coli
Perianal swabbing was done using sterile, moistened cot-
ton swabs. The collected samples were placed in Amies
transport media with charcoal (HiMedia, Mumbai,
India). Swabs were transported on ice to microbiology
diagnostic laboratory within four hours of collection.
Swabs were plated on MacConkey agar. All swabs grew
E. coli.
E. coli were identified by standard recommonded
methods [11]. Five colonies morphologically resembling
of E. coli were selected and identified biochemically [11].
A single isolate from the pool of five colonies was se-
lected for further characterization.
Phenotypic determination of antibiotic susceptibility
Antibiotic susceptibility testing was done using the Kirby-
Bauer disc diffusion method. Disc strengths were as
recommended by Clinical and Laboratory Standards
Institute (CLSI) guidelines [12]. The plates were incubated
at 35°C for 18 to 24 hours. Diameter and inhibition zones
produced by the antibiotic disc were measured to the
nearest millimetre. E. coli ATCC 25922 was used as the ref-
erence strain. Antibiotics tested were: ampicillin, cefuroxime,
ceftriaxone, cefixime, ceftazidime, nalidixic acid, norfloxacin,
ciprofloxacin, ofloxacin, gentamicin, amikacin, chloram-
phenicol, tetracycline, co-trimoxazole, nitrofurantoin,
amoxicillin/clavulanate and piperacillin/tazobactum and
imipenem. For calculations all isolates showing zone of in-
hibition indicating intermediate susceptibility were consid-
ered resistant. Multi-drug resistance (MDR) isolates were
defined as those isolates having co-resistance to at least
three different antibiotic classes [13]. Resistance of the MDR
isolates was confirmed by Minimum Inhibitory Concentra-
tion (MIC) using agar dilution method for quinolones (cip-
rofloxacin, ofloxacin) and third generation cephalosporins
(cefotaxim, ceftazidime) according to CLSI guidelines [12].
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Extended Spectrum Beta-Latamase (ESBL) were
detected phenotypically by the combined disc diffusion
method with cefotaxime (30μg) and cefotaxime/
clavulanic acid (30/10 μg) and ceftazidime (30μg) and
ceftazidime/clavulanic acid (30/10 μg) according to CLSI
guidelines [12].
Detection of genotypic determinants for ESBLs and
resistance to quinolones
Multiplex Polymerase Chain reactions (PCR) were used to
detect genes coding for beta-lactamases. Total bacterial
DNA from selected MDR E. coli showing ESBL production
phenotypically was extracted by alkaline lysis method [14].
Amplification and identification of ESBL encoding genes
(blaCTX-M, blaTEM and blaSHV) was done using previously
described primers [15].
A separate multiplex PCR was done for detecting plas-
mid mediated quinolone resistance genes (PMQR; qnrA,
qnrB, qnrS, aac(6′)-Ib-cr and qepA) using previously de-
scribed primers [16]. After PCR amplification, products
were visualized under gel documentation system. Chro-
mosomally mediated quinolone resistance was detected
using PCR and DNA sequencing of gyr A and par C genes
[17]. The purified PCR products were sequenced with ABI
3730XL (Applied Biosystems, USA) sequencer. The nu-
cleic acid sequences were analyzed by Basic Local Align-
ment Search Tool available at the National Center for
Biotechnology database. The nucleic acid sequences were
submitted to Genbank (GenBank accession numbers-
KC795246 - KC 795255, KC795239 - KC795245,
KC788561, KC788562).
Rep-PCR typing of MDR E. coli isolates
The molecular epidemiology of the MDR E. coli was
done by Rep-PCR using BOX A1R (5΄-CTACGGC
AAGGCGACGCTGACG-3΄) primers as previously
described [18]. PCR analysis was performed on a total
of 25 ml reaction mixture using 3 μl of total bacterial
DNA, as previously reported. PCR products were then
separated by electrophoresis in 1.5% agarose gels with
1XTAE running buffer at 8V/cm for 70 minutes and
stained with Ethidium bromide (0.5μg/ml), (Sigma
Aldrich), for 30 minutes and visualized using a
UV trans-illuminator. DNA molecular weight marker
(O’GenerulerTM 100 bp DNA ladder; Fermentas) was used
as a molecular size standard. Gel images were normalized,
bands were identified and the data were statistically analysed
by using Bionumerics software version 3.5 (Applied Maths,
Kortrijk, Belgium). Clustering of patterns was performed by
Unweighted Pair Group with Arithmetic averages
(UPGMA) and dendrogram was created using the Dice
Similarity Coefficient [18].
Statistical analysis
The data was entered in EpiData Entry (version 3.1) and
then transferred to Stata 10.0 (Stata Corp. College Sta-
tion, Texas, USA) software for statistical analysis. Fre-
quency and percentages are presented for categorical
data. Pearson Chi square test with 95% confidence inter-
val (95% CI) was used to calculate odds ratios (OR) for
potential risk factors associated with outcome variable
carriage of MDR isolates of E. coli. Crude ORs were cal-
culated from two by two tables. Multi-variable logistic
regression models were used to calculate adjusted OR in
the final model. The dichotomized explanatory variables
included were, occupation of the breadwinner (self
employed versus salaried), reported antibiotic use in
the previous four weeks (yes versus no), reported
hospitalization in the previous four weeks (yes versus
no). Categorical variables included, age group in years
(15 to 19, 20 to 29, 30 to 39 and 40 to 45), family size
(less than or equal to 4, 5 to 10 and more than 10 mem-
bers) and education (illiterate, up-to primary, up-to
higher secondary and graduate or post-graduate). A P
value less than or equal to 0.05 was considered signifi-
cant. The goodness of fit for the model was tested by
examining the Receiver Operating Characteristics (ROC)
curve plot [19]. The area under the ROC curve was
0.944 for the model for MDR E. coli meeting the criteria
for excellent model determination [19].
Results
Study population and enrolment
A total of 730 women were approached of which 710
were enrolled. Of the 710 women enrolled, 412 (58%)
were from teaching hospital and remaining from the
non-teaching hospital. The mean age of the women was
26 years (95% confidence interval, CI 26 to 27, range 15
to 44 years) (Table 1).
Detection of antibiotic-resistant phenotype and factors
associated with carriage of MDR E. coli
The antibiotic resistance pattern to selected antibiotics
for 710 E. coli isolates from 710 antenatal women is
shown in Table 2. A high number (n = 668, 94%; 95% CI
92.4 to 95.8) of E. coli isolates showed resistance to at
least one of the groups of antibiotics tested. All the iso-
lates were susceptible to imipenem. Resistance was
found to the commonly prescribed oral antibiotics, nali-
dixic acid (77%), tetracycline (69%), ampicillin (55%), co-
trimoxazole (48%), cefixime (32%), ciprofloxacin (28%)
and amoxicillin/clavulanate (27%). The resistance to
third generation cephalosporins was seen in the range of
17 to 19% and that to piperacillin/tazobactam and
amikacin 3% and 7% respectively.
Of the 127 isolates that were resistant to third gener-
ation cephalosporins, 109 isolates were seen to produce
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ESBLs and of these 35 isolates were MDR. MIC50 and
MIC90 for cefotaxime, ceftazidime, norfloxacin, cipro-
floxacin and ofloxacin were calculated for these isolates
(Table 3). The assay for MIC showed high levels of re-
sistance to third generation cephalosporins and
quinolones.
The statistically significant factors associated with car-
riage of MDR E. coli are shown in Table 1 and are as fol-
lows: “graduate or post-graduate education” Odds Ratio
(OR) 3.98 (95% CI 1.05 to 15.10; P = 0.04); “self
employed” OR 0.41 (95% CI 0.15 to 1.06; P = 0.05); “fam-
ily size more than 10 members” OR 4.97 (95% CI 1.51 to
16.33; P = 0.008); reported “antibiotic usage in last four
weeks” OR 17.01 (6.35 to 45.51; P < 0.001) and “history
of hospitalization in the last four weeks” OR 26.99 (95%
CI 10.32 to 70.50; P < 0.001). The statistically significant
factors associated with carriage of ESBL producing iso-
lates are: “antibiotic usage in last four weeks” OR 5.21
(3.12 to 11.28; P < 0.001) and “history of hospitalization
in the last four weeks” OR 7.82 (95% CI 4.31 to 10.50;
P < 0.001).
Detection of antibiotic resistance coding genes
The multiplex PCR was done for detection of beta-
lactamase producing genes. Of the 35 MDR isolates,
plasmid mediated resistance to cephalosporins was due
to blaCTX-M-15 (26/35 = 74%), blaTEM −1(26/35 = 74%)
and blaOXA-1(17/35 = 49%). The blaCTX-M-15 and blaTEM-1
were seen in 19 (54%), blaCTX-M-15 and blaOXA-1 in 15
(43%), blaTEM-1 and blaOXA-1 in 12 (34%) and blaCTX-M-15,
blaTEM-1 and blaOXA-1 in 12 (34%). All cefotaxime and
ceftazidime resistant isolates were also screened for the
presence of the blaSHV gene and none was found to carry
it. We sequenced TEM gene and all were found to be
TEM-1. The screening for PMQR genes showed one iso-
late positive for qnrA, one for qnrS1 gene and 23 isolates
were positive for aac(6′)-Ib-cr. It was note worthy that all
the isolates carrying PMQR genes also carried the blaTEM-1
Table 1 Multiple logistic regression analysis of factors associated with carriage of multi-drug resistant E. coli among
healthy women attending antenatal clinics in two hospitals in Ujjain, India
Factor Total MDR
n = 710 %a n = 35 %a OR (95% CI) P value
Age (in years)b
15 to 19 55 95 2 5 1
20 to 29 434 94 20 6 0.59 (0.13-2.67) 0.49
30 to 39 201 94 10 6 0.50 (0.09-2.70) 0.42
40 to 45 20 80 3 20 2.19 (0.23-20.9) 0.49
Educationb
Illiterate 393 94 17 6 1
Up-to primary 240 97 6 3 0.69 (0.21-2.18) 0.53
Up-to higher secondary 47 91 3 9 1.27 (0.26-6.27) 0.76
Graduate or post graduate 30 60 9 40 3.98 (1.05-15.10) 0.04
Occupation
Salaried 207 87 19 13 1
Self-employed 503 96 16 4 0.41 (0.15-1.06) 0.06
Family sizeb
Less than or equal to 4 339 94 14 6 1
Between 5–10 321 96 10 4 0.51 (0.17-1.47) 0.21
More than 10 50 70 11 30 4.97 (1.51-16.33) 0.008
Reported antibiotic usage (last 4 weeks)
No 663 97 13 3 1
Yes 47 36 22 64 17.01 (6.35-45.51) <0.001
Reported Hospitalization (last 4 weeks)
Yes 659 97 13 3 1
No 51 41 22 59 26.99(10.32-70.5) <0.001
%a row percentage; b The first value within the variable acted as reference value for logistic regression; OR- Odds ratio; CI-confidence interval;
OR significant at P = 0.05 are shown in bold face; MDR- multi-drug resistance (co-resistance to three different classes of antibiotics).
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and blaCTX-M-15 gene. There were 17 isolates having both
blaCTX-M-15 and aac(6′)-Ib-cr genes (Figure 1). PCR and
DNA sequencing for mutations in gyr A and par C genes
indicated chromosomally mediated quinolone resistance.
Sequence analysis of these genes indicated that all the 35
isolates had amino acid substitutions at QRDR regions at
gyr A (D87N/ S83L) and par C (S 80l) genes.
Chromosomally mediated resistance to quinolones
was seen in all the 35 isolates based on the presence of
gyrA and parC genes. Plasmid mediated resistance to
cephalosporins and quinolones was seen in 22/35 (63%).
Of these 21 isolates carried the aac(6′)-Ib-cr genes and
only one isolate carried the qnrS along with blaCTX-M-15,
blaTEM-1 and blaOXA-1 The other qnrA and qnrS genes
carrying plasmid were seen along with the plasmid cod-
ing for cephalosporin resistance. Details of MDR isolates
along with MIC values are included in the supplemen-
tary data (Additional file 1: Table S1). The dendrogram
(Figure 1) depicts the genetic similarity of MDR E .coli.
The genes coding for plasmid mediated and chromo-
somally mediated resistance to cephalosporins and
quinolones are also depicted at Figure 1.
Discussion
In the present study it was found that out of the 710 E.
coli isolated from women attending antenatal clinics in
Ujjain, India 94% were resistant to at least one of the
antibiotic groups tested. The statistically significant fac-
tors associated with carriage of MDR E. coli were better
education, overcrowding (family size more than 10
Table 3 MICs of 35 MDR commensal E. coli isolates
Antibiotic Range (μg/mL) MIC 50 (μg/mL) MIC90 (μg/mL)
Ciprofloxacin 0.125-512 128 256
Norfloxacin 0.125-512 512 >512
Ofloxacin 0.125-512 64 128
Cefotaxime 0.125-512 >512 >512
Ceftazidime 0.125-512 32 128
Figure 1 Dendrogram of Rep-PCR patterns showing the genetic relatedness of 35 MDR E. coli isolates.
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members) history of antibiotic use and/or hospitalization
in the last four weeks.
Quinolone resistance is usually chromosomally medi-
ated [20]. All 35 multi-resistant isolates showed presence
of gyrA and parC genes, which are chromosomally me-
diated. The aac(6′)-Ib-cr gene accounted for 95% of the
PMQR genes. Similar findings in pathogenic E. coli have
been reported elsewhere in India [21] and in E. coli iso-
lated from hospital wastewater in our setting [22]. Plas-
mid mediated resistance to cephalosporins was largely
due to blaCTX-M -15 which is in keeping with other stud-
ies done in India [21,23]. The blaTEM-1 is not been
subtyped therefore no comment can be made for its co-
relation with ESBL production. It is interesting to note
that blaSHV was not detected. The presence of genes
coding for extended spectrum of beta lactamases and
plasmid mediated quinolone resistance in commensal
E. coli is disconcerting.
Studies from India [7,24] and other low-middle in-
come countries [25] have reported lower rates of resist-
ance (range of 32 to 63%) to a single antibiotic
compared to the present study (94%). The difference in
the resistance rates could be due to variation in the geo-
graphical area of the study [7,8,26] and also is dependent
on the pattern of antibiotic prescribing in the local com-
munity [27,28]. The ESBL rate (15%) in the present
study is lower than that reported among pathogenic
E. coli (69%) isolated from patients with clinical infec-
tions in the same geographical area [29].
The majorities of women enrolled in the study were
either illiterate or had only a primary education (Table 1).
Women with higher education had a higher likelihood
of carriage of MDR E. coli. This could be a chance asso-
ciation and needs further validation. But, women with
higher education may also be socio-economically better
off and thus more likely to seek health-care and conse-
quently have a greater exposure to antibiotics [30]. Most
self-employed women enrolled in the study were daily
wage workers, and consequently, probably, had limited
opportunity to seek medical care, limiting their anti-
biotic exposure.
Exposure to hospital environment especially hospitalization
in intensive care units is a major risk factor for carriage of
multi-drug resistant bacteria especially in resource
poor settings where hospitals can have high infection
rates and spread of multi-drug resistant pathogens
[25,31]. A multitude of factors including poor infrastruc-
ture of hospitals, low compliance with hand-hygiene,
heavy workload with understaffing, overcrowding, lack of
or poorly functioning infection control programme con-
tribute to the problem [31].
In the present study a significantly higher MDR car-
riage among women living in larger families (more than
10 members), OR 4.97 (95% CI 1.51 to 16.33; P = 0.008)
was found. Similar results have been reported in post-
menopausal women in our setting [32]. Over-crowding
combined with inadequate hygiene and sanitary facilities
and sewage disposal, would lead to greater sharing of
commensal flora in families and communities [8,32]. In
a study among primary school children in rural Tamil
Nadu over crowding in classrooms was associated with
increased carriage of antibiotic resistant commensal
E. coli [24]. Thus, the dynamics of bacterial transmission
due to over crowding is worthy of further investigation.
The rate and amount of antibiotic use in community
an important determinant of increasing antibiotic resist-
ance in bacteria [27,28]. A meta analysis and review on
the effect of antibiotic prescribing in a primary-care set-
ting on antimicrobial resistance in individual patients in-
cluded five studies of urinary tract infections (14348
participants), the pooled odds ratio (OR) for resistance
was 2.5 (95% CI 2.1 to 2.9) within two months of anti-
biotic treatment [33]. The OR at one month (only one
study) was 6.1 (95% CI 2.8 to 13.4) [33]. Recent anti-
biotic use was associated with increased risk of carriage
of resistant E. coli, OR 1.8 (95% CI 1.5 to 2.3) in a study
from Indonesia [25].
The ESBL production is the commonest mechanism of
resistance to cephalosporins in Enterobacteriaceae [2].
Phenotypic detection of ESBL production was in 15%
isolates in the present study, which is much lower than
the 51% reported in a study from China [34].
The blaCTX-M-15 and blaTEM −1 coded genes are wide-
spread in E. coli [2]. The detection of bla CTX-M-15 and
blaTEM-1 genes as shown in Figure 1 is similar to that in
Latin America [9]. In the present study it has been noted
that a majority of MDR E coli isolates (48%) were carry-
ing aac(6′)-Ib-cr gene. These isolates also showed high
MIC to ciprofloxacin and ofloxacin probably due to
chromosomally mediated resistance (par A and par C)
(Table 3). Co-residence of bla CTX-M-15, qnr and aac(6′)-
Ib-cr genes on the same plasmid has been reported else-
where [35].
PMQR genes code for low levels of quinolone resist-
ance [36]. The presence of PMQR gene in MDR isolates
was 4%, which is similar to that in a study from Republic
of Korea [16]. It is interesting to notice that chromosomal
mediated quinolone resistance coded by mutation in
QRDR regions of gyr A and par C genes was present in all
MDR E coli isolates in the present study. A study in
Ghana on quinolone-resistant E. coli in the faecal flora
also reported the presence of qnr genes and amnio acid
substitutions at gyrA and par C genes [37].
An analysis of resistance pattern of commensal E. coli
can be helpful in deciding empiric treatment of choice
for suspected neonatal infections. Neonatal sepsis with
multi-drug resistant gram negative organisms resistant
to ampicillin, third generation cephalosporins and
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gentamicin caused high mortality (26%) in neonates in a
neonatal intensive care unit (NICU) in India [38]. The
current choices of therapy in our NICU are in line with
the most sensitive patterns described ie third generation
cephalosporins along with an aminoglycoside (Table 2).
However, the last resort antibiotics (eg. vancomycin and
imipenem) are now increasingly being used in view of
increasing resistance [29] in our NICU to salvage septic
neonates.
The most important strength of this study is the com-
bination of epidemiological and molecular methods for
the identification of factors associated with carriage of
resistant bacteria. Antenatal women are a population,
which is at a low risk for receiving antibiotics. Despite
this a history of antibiotic therapy was identified as an
important risk factor associated with carriage of resistant
bacteria. The fact underscores the importance of pru-
dent antibiotic use. A structured questionnaire was used
which could have resulted in us missing other factors re-
lated to carriage of resistant E. coli like environmental
factors and food chain related factors.
Conclusions
The presence of antibiotic resistance mediating genes in
commensal bacteria provides information on the occur-
rence of multi-drug resistance bacteria in a given geo-
graphical area. The presence of genes coding for
extended spectrum of beta lactamases and plasmid me-
diated quinolone resistance in commensal E. coli is
disconcerting.
This is compounded in resource poor settings with
overcrowding and poor sanitation, which seem to aid
the spread of multi-drug resistant bacteria within a com-
munity. This provides strong basis of good antibiotic
stewardship.
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